Eurofins Scientific SE/ FR0014000MR3 /
| 6/2/2023 5:29:42 PM | Chg. +0.44 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 61.48EUR | +0.72% | 148,554 Turnover: 3.62 mill. |
-Bid Size: - | -Ask Size: - | 11.86 bill.EUR | 1.62% | 17.25 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.57 EUR | -12.71% |
| EPS Diluted: | - EUR | -11.54% |
| Revenues per Share: | 34.87 EUR | -0.60% |
| Book Value per Share: | 24.84 EUR | 2.36% |
| Cash Flow per Share: | 5.90 EUR | -25.21% |
| Dividend per Share: | 1.00 EUR | 47.06% |
| Total | in mill. | |
| Revenues: | 6,712.10 EUR | -0.08% |
| Net Income: | 687.40 EUR | -12.16% |
| Operating Cash Flow: | 1,136.30 EUR | - |
| Cash and Cash Equivalents: | 486.60 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 17.25 | - |
| P/S Ratio: | 1.77 | - |
| P/BV ratio: | 2.48 | - |
| P/CF Ratio: | 10.44 | - |
| PEG: | -1.36 | - |
| Earnings Yield: | 5.80% | - |
| Dividend Yield: | 1.62% | - |
| Market Capitalization | ||
| Market Capitalization: | 11.86 bill. EUR | 0.0000 EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 193,193.1117 EUR | - EUR |
| Shares Outstanding: | 190.79 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 15.45% |
| Net Profit Margin: | 10.24% |
| Return on Equity: | 14.37% |
| Return on Assets: | 6.82% |
Financial Strength
| Liquidity I / Cash Ratio: | 27.46% |
| Liquidity II / Quick Ratio: | 86.89% |
| Liquidity III / Current Ratio: | 130.53% |
| Debt / Equity Ratio: | 0.00% |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | 61,379 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 109,354.99 EUR |
| Net Income / Employee: | 11,199.27 EUR |
| Total Assets / Employee: | 164,282.57 EUR |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | IFRS |
| Currency: | EUR |